Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis

Journal of Cell Biology

Volumn 140, Issue 2, 1998, Pages 419-430

  Kyriakides, Themis R ^a   Zhu, Yu Hong ^a   Smith, Lynne T ^b   Bain, Steven D ^c   Yang, Zhantao ^a   Lin, Ming T ^a   Danielson, Keith G ^d   Iozzo, Renato V ^d   LaMarca, Mary ^e   McKinney, Cindy E ^e   Ginns, Edward I ^e   Bornstein, Paul ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ZYMOGENETICS INC   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLLAGEN FIBRIL; DNA; PROTEIN; RNA; THROMBOSPONDIN; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLEEDING TENDENCY; BLEEDING TIME; BLOOD VESSEL; CELL ADHESION; CELL MIGRATION; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; DENSITY; ELECTRON MICROSCOPY; EMBRYO; GENE; IMMUNOBLOTTING; MESENCHYME CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN; SKIN FIBROBLAST; TENDON; TENSILE STRENGTH;

ANIMALS; BONE DENSITY; CELL ADHESION; CELL ADHESION MOLECULES; COLLAGEN; CONNECTIVE TISSUE; HEMORRHAGIC DISORDERS; MICE; MICE, KNOCKOUT; PHENOTYPE; TAIL; TENDONS; THROMBOSPONDINS;

ANIMALIA;

EID: 0032567684     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.140.2.419     Document Type: Article

References (58)

1. Adams, J.C. 1995. Formation of stable microspikes containing actin and the 55 kda actin bundling protein, fascin, is a consequence of cell adhesion to thrombospondin-1: implications for the anti-adhesive activities of thrombospondin-1. J. Cell Sci. 108:1977-1990.
2. Adams, J.C., and J. Lawler. 1993. Diverse mechanisms for cell attachment to platelet thrombospondin. J. Cell Sci. 104:1061-1071.
3. Andrikopoulos, K., X. Liu, D.R. Keene, R. Jaenisch, and F. Ramirez. 1995. Targeted mutation in the Col5α2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat. Genet. 9:31-36.
4. Aumailley, M., K. Mann, H. von der Mark, and R. Timpl. 1989. Call attachment properties of collagen type VI and Arg-Gly-Asp dependent binding to its α2(VI) and α3(VI) chains. Exp. Cell Res. 181:463-174.
5. Barabino, G.A., R.J. Wise, V.A. Woodbury, B.B. Zhang, K.A. Bridges, R.P. Hebbel, J. Lawler, and B.M. Ewenstein. 1997. Inhibition of sickle erythrocyte adhesion to immobilized thrombospondin by von willebrand factor under dynamic flow conditions. Blood. 89:2560-2567.
6. Birk, D.E., and R.L. Trelstad. 1986. Extracellular compartments in tendon morphogenesis: collagen fibril, bundle, and macroaggregate formation. J. Cell Biol. 103:231-240.
7. Birk, D.E., and T.F. Linsenmayer. 1994. Collagen fibril assembly, deposition, and organization into tissue-specific matrices. In Extracellular Matrix Assembly and Structure. P.D. Yurchenco, D.E. Birk, and R.P. Mecham, editors. Academic Press, San Diego, CA. 91-128.
8. Bonyadi, M., S.B. Rusholme, F.M. Cousins, H.C. Su, C.A. Biron, M. Farrall, and R.J. Akhurst. 1997. Mapping of a major genetic modifier of embryonic lethality in TGFβ1 knockout mice. Nat. Genet. 15:207-211.
9. Bornstein, P. 1992. The thrombospondins: structure and regulation of expression. FASEB (Fed. Am. Soc. Exp. Biol.) J. 6:3290-3299.
10. Bornstein, P. 1995. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J. Cell Biol. 130:503-506.
11. Bornstein, P., and E.H. Sage. 1994. Thrombospondins. Methods Enzymol. 245: 62-85.
12. Bornstein, P., S. Devarayalu, P. Li, C.M. Disteche, and P. Framson. 1991a. A second thrombospondin gene in the mouse is similar in organization to thrombospondin 1 but does not respond to serum. Proc. Natl. Acad. Sci. USA. 88:8636-8640.
13. Bornstein, P., K. O'Rourke, K. Wikstrom, F.W. Wolf, R. Katz, P. Li, and V.M. Dixit. 1991b. A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. J. Biol. Chem. 266:12821-12824.
14. Bouck, N. 1996. P53 and angiogenesis. Biochim. Biophys. Acta. 1287:63-66.
15. Bouck, N., V. Stellmach, and S.C. Hsu. 1996. How tumors become angiogenic. Adv. Cancer Res. 69:135-174.
16. Burrows, N.P., A.C. Nicholls, J.R.W. Yates, G. Gatward, P. Sarathachandra, A. Richards, and F.M. Pope. 1996. The gene encoding collagen α1(V) (COL5A1) is linked to mixed Ehlers-Danlos Syndrome type I/II. J. Investig. Dermatol. 106:1273-1276.
17. Byers, P.H. 1995. Disorders of collagen biosynthesis and structure. In The Metabolic and Molecular Bases of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill, Inc., New York. 4029-4077.
18. Chen, H., D.K. Strickland, and D.F. Mosher. 1996. Metabolism of thrombospondin 2: binding and degradation by 3T3 cells and glycosaminoglycan-variant chinese hamster ovary cells. J. Biol. Chem. 271:15993-15999.
19. Chen, H., J. Sottile, K.M. O'Rourke, V.M. Dixit, and D.F. Mosher. 1994. Properties of recombinant mouse thrombospondin 2 expressed in Spodoptera cells. J. Biol. Chem. 269:32226-32232.
20. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162:156-159.
21. Danielson, K.G., H. Baribault, D.F. Holmes, H.Graham, K.E. Kadler, and R.V. Iozzo. 1997. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136:729-743.
22. Ducy, P., C. Desbois, B. Boyce, G. Pinero, B. Story, C. Dunstan, E. Smith, J. Bonadio, S. Goldstein, C. Gundberg, A. Bradley, and G. Karsenty. 1996. Increased bone formation in osteocalcin-deficient mice. Nature. 382:448-452.
23. Frazier, W.A. 1991. Thrombospondins. Curr. Opin. Cell Biol. 3:792-799.
24. Galvin, N.J., P.M. Vance, V.M. Dixit, B. Fink, and W.A. Frazier. 1987. Interaction of human thrombospondin with types I-V collagen: Direct binding and electron microscopy. J. Cell Biol. 104:1413-1422.
25. Hayman, A.R., S.J. Jones, A. Boyde, D. Foster, W.H. Colledge, M.B. Carlton, M.J. Evans, and T.M. Cox. 1996. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development. 122:3151-3162.
26. Houdijk, W.P.M., P.G. de Groot, P.F.E.M. Nievelstein, K.S. Sakariassen, and J.J. Sixma. 1986. Subendothelial proteins and platelet adhesion. von Wille-brand factor and fibronectin, not thrombospondin, are involved in platelet adhesion to extracellular matrix of human vascular endothelial cells. Arteriosclerosis. 6:24-33.
27. Hynes, R.O. 1996. Targeted mutations in cell adhesion genes: what have we learned from them? Dev. Biol. 180:402-412.
28. Iozzo, R.V., and A.D. Murdoch. 1996. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB (Fed. Am. Soc. Exp. Biol.) J. 10: 598-614.
29. Iruela-Arispe, M.L., D.J. Liska, E.H. Sage, and P. Bornstein. 1993. Differential expression of thrombospondin 1, 2, and 3 during murine development. Dev. Dyn. 197:40-56.
30. Kadler, K.E., D.F. Holmes, J.A. Trotter, and J.A. Chapman. 1996. Collagen fibril formation. Biochem. J. 316:1-11.
31. Lafeuillade, B., S. Pellerin, M. Keramidas, M. Danik, E.M. Chambaz, and J.J. Feige. 1996. Opposite regulation of thrombospondin-1 and corticotropin-induced secreted protein/thrombospondin-2 expression by adrenocorticotropic hormone in adrenocortical cells. J. Cell. Physiol. 167:164-172.
32. Laherty, C.D., K. O'Rourke, F.W. Wolf, R. Katz, M.F. Seldin, and V. M. Dixit. 1992. Characterization of mouse thrombospondin 2 sequence and expression during cell growth and development. J. Biol. Chem. 267:3274-3281.
33. Laird, P.W., A. Zijderveld, K. Linders, M.A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4153.
34. Liu, X., H. Wu, M. Byrne, S. Krane, and R. Jaenisch. 1997. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc. Natl. Acad. Sci. USA. 94:1852-1856.
35. Marchant, J.K., R.A. Hahn, T.F. Linsenmayer, and D.E. Birk. 1996. Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal-specific fibril morphology. J. Cell Biol. 135:1415-1426.
36. McGregor, J.L., and H. Boukerche. 1993. Thrombospondin interaction with human blood platelets. In Thrombospondin. J. Lahav, editor. CRC Press, Boca Raton, FL. 111-127.
37. Mumby, S.M., G.J. Raugi, and P. Bornstein. 1984. Interactions of thrombospondin with extracellular matrix proteins: selective binding to type V collagen. J. Cell Biol. 98:646-652.
38. Murphy-Ullrich, J.E. and M. Höök. 1989. Thrombospondin modulates focal adhesions in endothelial cells. J. Cell Biol. 109:1309-1319.
39. Murphy-Ullrich, J.E., S. Gurusiddappa, W.A. Frazier, and M. Höök. 1993. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. J. Biol. Chem. 268:26784-26789.
40. Murphy-Ullrich, J.E., M.A. Pallero, N. Boerth, J.A. Greenwood, T.M. Lincoln, and T.L. Cornwell. 1996. Cyclic GMP-dependent protein kinase is required for thrombospondin and tenascin mediated focal adhesion disassembly. J. Cell Sci. 109:2499-2508.
41. Nicosia, R.F., and G.P. Tuszynski. 1994. Matrix-bound thrombospondin promotes angiogenesis in vitro. J. Cell Biol. 124:183-193.
42. Pellerin, S., B. Lafeuillade, E.M. Chambaz, and J.J. Feige. 1994. Distinct effects of thrombospondin-1 and CISP/thrombospondin-2 on adrenocortical cell spreading. Mol. Cell. Endocrinol. 106:181-186.
43. Ploetz, C., E.I. Zycband, and D.E. Birk. 1991. Collagen fibril assembly and deposition in the developing dermis: segmental deposition in extracellular compartments. J. Struct. Biol. 106:73-81.
44. Popoff, S.N., and S.C. Marks. 1995. The heterogeneity of the osteopetroses reflects the diversity of cellular influences during skeletal development. Bone. 17:437-445.
45. Roberts, D.D. 1996. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB (Fed. Am. Soc. Exp. Biol.) J. 10:1183-1191.
46. Sadler, J.E. 1995. von Willebrand disease. In The Metabolic and Molecular Bases of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill Inc., New York. 3269-3287.
47. Sherbina, N.V., and P. Bornstein. 1992. Modulation of thrombospondin gene expression during osteoblast differentiation in MC3T3-E1 cells. Bone. 13: 197-201.
48. Sipes. J.M., N.H. Guo, E. Negre, T. Vogel, H.C. Krutzsch, and D.D. Roberts. 1993. Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the 2nd type-I repeat of thrombospondin. J. Cell Biol. 121:469-477.
49. Sixma, J.J., and P.G. de Groot. 1994. Regulation of platelet adhesion to the vessel wall. Ann. NY Acad. Sci. 714:190-199.
50. Smith, L.T., U. Schwarze, J. Goldstein, and P.H. Byers. 1997. Mutations in the COL3A1 gene result in the Ehlers-Danlos Syndrome type IV and alterations in the size and distribution of the major collagen fibrils of the dermis. J. Investig. Dermatol. 108:241-247.
51. Stellmach, V., O.V. Volpert, S.E. Crawford, J. Lawler, R.O. Hynes, and N. Bouck. 1996. Tumour suppressor genes and angiogenesis: the role of TP53 in fibroblasts. Eur. J. Cancer. 32A:2394-2400.
52. Stomski, F.C., J.S. Gani, R.C. Bates, and G.F. Burns. 1992. Adhesion to thrombospondin by human embryonic fibroblasts is mediated by multiple receptors and includes a role for glycoprotein 88 (CD36). Exp. Cell Res. 198:85-92.
53. Taraboletti, G., D. Belotti, P. Borsotti, V. Vergani, M. Rusnati, M. Presta, and R. Giavazzi. 1997. The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor. Cell Growth Differ. 8:471-479.
54. Tucker, R.P. 1993. The in situ localization of tenascin splice variants and thrombospondin 2 mRNA in the avian embryo. Development. 117:347-358.
55. Tuszynski, G.P., and R.F. Nicosia. 1996. The role of thrombospondin-1 in tumor progression and angiogenesis. Bioessays. 18:71-76.
56. Vogel, A., K.A. Holbrook, B. Steinmann, R. Gitzelmann, and P.H. Byers. 1979. Abnormal collagen fibril structure in the gravis form (type I) of the Ehlers-Danlos syndrome. Lab. Invest. 40:201-206.
57. Volpert, O.V., S.S. Tolsma, S. Pellerin, J. Feige, H. Chen, D.F. Mosher, and N. Bouck. 1995. Inhibition of angiogenesis by thrombospondin-2. Biochem. Biophys. Res. Commun. 217:326-332.
58. Weiss, H.J. 1995. Flow-related platelet deposition on subendothelium. Thromb. Haemostasis. 74:117-122.